Cover Image
市場調查報告書

尋常痤瘡:全球臨床實驗趨勢

Acne Vulgaris Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 223318
出版日期 內容資訊 英文 324 Pages
訂單完成後即時交付
價格
Back to Top
尋常痤瘡:全球臨床實驗趨勢 Acne Vulgaris Global Clinical Trials Review, H1, 2017
出版日期: 2017年02月22日 內容資訊: 英文 324 Pages
簡介

本報告提供全球各國尋常痤瘡臨床實驗相關調查,各地區、進展狀況、各期、各募集情況的實驗量,代表性贊助商,正在開發的治療藥的資訊,各企業機關的進行狀況的資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:皮膚疾病治療藥臨床實驗上尋常痤瘡的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:皮膚疾病治療藥臨床實驗上尋常痤瘡的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

尋常痤瘡治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's clinical trial report, "Acne Vulgaris Global Clinical Trials Review, H1, 2017" provides an overview of Acne Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Acne Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
  • Top Five Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 11
  • Top Five Countries Contributing to Clinical Trials in Central and South America 12
  • Clinical Trials by G7 Countries: Proportion of Acne Vulgaris to Dermatology Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Acne Vulgaris to Dermatology Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Acne Vulgaris Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Latest Clinical Trials News on Acne Vulgaris 28
  • Feb 07, 2017: Vyome Announces Top-line Results from Phase 1 Study of VB-1953 for Patients with Facial Acne Vulgaris 28
  • Jan 27, 2017: Novan Reports Topline Results from SB204 Phase 3 Pivotal Trials 28
  • Jan 26, 2017: SPIE Photonics West Presentations to Show BioPharmX was First to Visualize Minocycline on the Skin Using Multiphoton Microscopy 29
  • Jan 12, 2017: BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline Gel 29
  • Jan 04, 2017: BioPharmX Completes Enrollment of BPX-01 Phase 2b OPAL Clinical Trial for Acne Vulgaris 30
  • Jan 03, 2017: Dermira Initiates Phase 3 Clinical Program in Acne 30
  • Dec 01, 2016: BioPharmX Poster at ASCB Annual Meeting to Show Topical Minocycline Has Potential to Deliver Non-Antibiotic Benefits 31
  • Nov 28, 2016: Foamix Announces Completion of Patient Enrollment in Phase 3 Acne Trials for Minocycline Foam FMX101 31
  • Clinical Trial Profile Snapshots 32

Appendix 324

  • Abbreviations 324
  • Definitions 324
  • Research Methodology 325
  • Secondary Research 325
  • About GlobalData 326
  • Contact Us 326
  • Disclaimer 326
  • Source 327

List of Tables

List of Tables

  • Acne Vulgaris Therapeutics, Global, Clinical Trials by Region, 2017* 5
  • Acne Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
  • Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
  • Acne Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 8
  • Acne Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 9
  • Acne Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2017* 10
  • Acne Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 11
  • Acne Vulgaris Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 12
  • Proportion of Acne Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
  • Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Acne Vulgaris to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
  • Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Acne Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2017* 19
  • Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
  • Acne Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Acne Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Acne Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures

List of Figures

  • Acne Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2017* 5
  • Acne Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
  • Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 7
  • Acne Vulgaris Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 8
  • Acne Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 9
  • Acne Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 10
  • Acne Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 11
  • Acne Vulgaris Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 12
  • Proportion of Acne Vulgaris to Dermatology Clinical Trials, G7 Countries (%), 2017* 13
  • Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 14
  • Acne Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 15
  • Proportion of Acne Vulgaris to Dermatology Clinical Trials, E7 Countries (%), 2017* 16
  • Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 17
  • Acne Vulgaris Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Acne Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
  • Acne Vulgaris Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
  • Acne Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Acne Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Acne Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Acne Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
  • GlobalData Methodology 325
Back to Top